Charles River Laboratories International (CRL) Other Non Operating Income (2009 - 2026)

Charles River Laboratories International has reported Other Non Operating Income for 18 years, with the latest figure at -$37.4 million in Q2 2026.

• On a quarterly basis, Other Non Operating Income fell 24392.21% year-over-year to -$37.4 million in Q2 2026; TTM through Jun 2026 was -$172.1 million, a 434.84% decrease from a year earlier, with the FY2025 full-year figure at -$22.6 million, down 36.66% from the prior year.
• Other Non Operating Income was -$37.4 million for Q2 2026 at Charles River Laboratories International, up from -$124.1 million in the prior quarter.
• The five-year high for Other Non Operating Income was $115.5 million in Q4 2022, with the low at -$124.1 million in Q1 2026.
• Average Other Non Operating Income over 5 years is -$4.1 million, with a median of -$4.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Other Non Operating Income surged 5476.59% in 2022, then sank 24392.21% in 2026.
• Over 5 years, Other Non Operating Income stood at $115.5 million in 2022, then dropped by 6.76% to $107.7 million in 2023, then sank by 121.07% to -$22.7 million in 2024, then jumped by 153.29% to $12.1 million in 2025, then sank by 409.2% to -$37.4 million in 2026.
• The last three Other Non Operating Income figures came in at -$37.4 million (Q2 2026), -$124.1 million (Q1 2026), and $12.1 million (Q4 2025), per Business Quant data.